Novo Nordisk’s Wegovy Pill Gains Momentum, but Eli Lilly Sees Lead Intact
The weight loss drug market is moving faster than ever, and the competition among major pharmaceutical companies continues to…
-
-
Eli Lilly’s Retatrutide Achieves Significant Weight Loss in Clinical Trial
The phase 3 trial findings for Eli Lilly’s experimental treatment for obesity, retatrutide, were declared as successful. According to…
-
Eli Lilly Reports Robust First Quarter Financial Results
Eli Lilly reported first-quarter results that surpassed market expectations. Management subsequently raised full-year revenue and earnings guidance. This revision…
-
Eli Lilly’s Foundayo Records 1,390 Prescriptions in Launch Week as Oral Obesity Drug Competition Intensifies
Eli Lilly recently rolled out Foundayo within the competitive obesity treatment market. Initial tracking data shows that physicians wrote…
-
Eli Lilly Launches Oral Weight-Loss Drug and Acquires Centessa Pharmaceuticals for $6.3 Billon
Eli Lilly, a leading pharmaceutical company, made two significant strategic initiatives to increase its market share. Foundayo, the company’s…
-
Orforglipron Surges Ahead: Eli Lilly’s Oral GLP-1 Pill Beats Oral Semaglutide in Landmark Diabetes Trial
Eli Lilly has unveiled striking results from a head-to-head clinical trial showing its experimental oral GLP-1 pill, Orforglipron, outperformed…
-
Lilly Wins FDA Nod for Zepbound Multi-Dose Pen, Boosting Convenience in Booming Weight-Loss Market
Eli Lilly and Company has won approval from the U.S. Food and Drug Administration for a new multi-dose version…
-
Lilly Bets Big on Obesity Pill, Leaving Peptron Deal in Limbo
Eli Lilly and Company is accelerating its push into the fast-growing obesity drug market. However, its renewed focus on…
-
Eli Lilly Stock Jumps as $1.5 Billion Weight-Loss Pill Nears Market Launch
Shares of Eli Lilly and Company moved higher this week after the drugmaker signaled strong confidence in its upcoming…
-
From Needles to Pills: Big Pharma’s High-Stakes Race to Redefine Weight Loss
Pharmaceutical companies are racing to transform weight‑loss treatment. They are shifting from weekly injections to daily pills, opening easier…
